Race for coronavirus treatment - As the global race continues to try and find a treatment for coronavirus the UK biotech firm Synairgen is reportedly planning to trial its experimental lung drug on Covid-19 patients.
The company received the green light from UK regulators to conduct a trial of its lead drug SNG001 at NHS trusts across the country.
The inhaled drug has been in development as a treatment for chronic-obstructive pulmonary disorder (COPD), a severe lung disease, but this has been paused to conduct testing on 100 patients who have been diagnosed with Covid-19.
It was identified in a WHO analysis of potential treatments against the coronavirus. Patients can self-administer it, through a small hand-held battery-operated nebulizer.
The trial is due to start next week.
French Prime Minister Jean Castex has signed an agreement which increases the pay of medical workers
Read More
A 26-year-old man has been shot dead in Toulouse in the early hours of this morning. The victim is the younger brother of footballer Serge Aurier, ...
Read More
A 17-year-old boy has been stabbed to death after a fight broke out amongst several teenagers on Sunday. The incident occurred shortly after 8pm in th...
Read More
Sante Publique France have said today that they have noted "a new trend towards an increase in the circulation" of the coronavirus...
Read More
The Landsberg beach in Saint Laurent du Var located between the promenade des Flots Bleus and Cap 3000 is to remain closed for the summer due to pollu...
Read More
